Pacific Biosciences of California PACB Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's change in other liabilities?
- Pacific Biosciences of California (PACB) reported change in other liabilities of $5.13M in Q1 2026.
- How has Pacific Biosciences of California's change in other liabilities changed year-over-year?
- Pacific Biosciences of California's change in other liabilities increased by 118.8% year-over-year, from $2.35M to $5.13M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.